Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einar Gude

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Transplantation|June 17, 2011
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trialSatish Arora, Thor Ueland, Bertil Wennerblom, et al.
Transplantation|January 12, 2010
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trialLars Gullestad, Martin Iversen, Svend-Aage Mortensen, et al.
Clinical Transplantation|February 11, 2017
Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimensBritta S Bürker, Lars Gullestad, Einar Gude, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2018
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppressionHilde M Norum, Annika E Michelsen, Tove Lekva, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Frontiers in Immunology|October 10, 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertensionHenriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
Circulation|June 27, 2025
New Algorithm for Estimating Left Ventricular Filling Pressure by EchocardiographyHossam Lababidi, Wissam Rahi, Otto A Smiseth, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
Journal of the American College of Cardiology|April 15, 2017
Estimating Left Ventricular Filling Pressure by EchocardiographyOyvind S Andersen, Otto A Smiseth, Hisham Dokainish, et al.
JACC. Advances|June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac AmyloidosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Transplantation|June 17, 2011
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trialSatish Arora, Thor Ueland, Bertil Wennerblom, et al.
Transplantation|January 12, 2010
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trialLars Gullestad, Martin Iversen, Svend-Aage Mortensen, et al.
Clinical Transplantation|February 11, 2017
Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimensBritta S Bürker, Lars Gullestad, Einar Gude, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2018
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppressionHilde M Norum, Annika E Michelsen, Tove Lekva, et al.
ESC Heart Failure|March 11, 2025
Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantationMargrethe Flesvig Holt, August Flø, Esra Kaya, et al.
Frontiers in Immunology|October 10, 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertensionHenriette Didriksen, Øyvind Molberg, Adi Mehta, et al.
Circulation|June 27, 2025
New Algorithm for Estimating Left Ventricular Filling Pressure by EchocardiographyHossam Lababidi, Wissam Rahi, Otto A Smiseth, et al.
International Journal of Cardiology|January 25, 2024
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohortAlessandro De Bortoli, Ingvild Nordøy, James Patrick Connelly, et al.
Journal of the American College of Cardiology|April 15, 2017
Estimating Left Ventricular Filling Pressure by EchocardiographyOyvind S Andersen, Otto A Smiseth, Hisham Dokainish, et al.
JACC. Advances|June 26, 2025
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac AmyloidosisMargrethe Flesvig Holt, Annika E Michelsen, August Flø, et al.
Pageof 10